WEDERM
Corée du Sud
standard
Site web: https://wedermglobal.com/
Marques : AETERDERM, PURIHILO PN, ABEP, PURILAX, LEXYFILL, PURI EYES, PuriTox, HAIRIZ
Numéro de stand : K235
Catégorie
- Injectables: Produits de comblement
- PRP - Médecine régénérative - Banque de cellules souches
- Injectables: Toxines botuliniques
Profil de l'entreprise
WEDERM Co., Ltd. is a Seoul-based medical aesthetics company founded in 2021, developing and exporting HA fillers, botulinum toxin, skin boosters, and lipolysis solutions under its own brand AETERDERM. WEDERM manages the full cycle from R&D to manufacturing and branding, and exports to around 30 countries across Asia, Russia/CIS, Europe, and the Americas.
At IMCAS World 2027, WEDERM presents AETERDERM PURIHILO PN, a hybrid skin booster combining 40 mg high-molecular HA and 40 mg low-molecular HA with 25 mg polynucleotide in a 2.5 mL syringe. Stabilized through the PCT-patented ABEP acid-base equilibrium process, it binds HA without BDDE or heat treatment, preserving ingredient integrity and eliminating cross-linker-related side effects. Fewer injection points, less discomfort, deep hydration from HA, and skin regeneration and elasticity from PN.
Visit our booth to discover the AETERDERM PURI line.
At IMCAS World 2027, WEDERM presents AETERDERM PURIHILO PN, a hybrid skin booster combining 40 mg high-molecular HA and 40 mg low-molecular HA with 25 mg polynucleotide in a 2.5 mL syringe. Stabilized through the PCT-patented ABEP acid-base equilibrium process, it binds HA without BDDE or heat treatment, preserving ingredient integrity and eliminating cross-linker-related side effects. Fewer injection points, less discomfort, deep hydration from HA, and skin regeneration and elasticity from PN.
Visit our booth to discover the AETERDERM PURI line.